TÜBINGEN, Germany and BERLIN, July 31, 2017 /PRNewswire/ -- The 5th International
Hundreds of world renowned innovators, scientists, academia and pharmaceutical delegates are expected to attend the conference as mRNA therapeutic technology evolves from scientific concept to medical application. Approximately 25 speakers will present on preclinical and clinical development in the fields of oncology, infectious diseases and molecular therapies as well as mRNA delivery, design and product development. Additionally, a poster session will provide research groups and company representatives the opportunity to showcase their data to attendees.
Ingmar Hoerr, Ph.D., founding member of the International mRNA Health Conference and CEO of CureVac, commented, "The mRNA industry has witnessed a multitude of transformational events over the past twelve months, with multiple programs being pushed through the clinic and companies developing infrastructure to prepare for eventual commercialization efforts. It seems that every year since our colleagues from Moderna, BioNTech and we began hosting this meeting, we grow substantially closer to realizing mRNA as an actual medical application. Academics and industry continue to break new ground in understanding the vast potential of the technology across multiple therapeutic fields. With the conference entering its fifth year, we are delighted to welcome our colleagues in the field to celebrate another successful year of mRNA research and development as we bring our vision closer to realization."
The 5th International mRNA Health Conference
Date: November 1-2, 2017
Place: Berlin, Germany
Location: Sofitel Berlin Kurfürstendamm, Augsburger Strasse 41, 10789 Berlin, Germany
Program: The Conference will provide a comprehensive program around the medical use of Messenger RNA. The Science Committee of the Conference with members from three leading mRNA companies, BioNTech, CureVac and Moderna Therapeutics, is calling for abstracts for a potential talk or poster presentation during the conference – see http://mrna-conference.com/program-speakers/
Registration: Register by September 15th and benefit from early bird prices under http://mrna-conference.com/register/
Verena Lauterbach, Senior Manager CommunicationsCureVac AG, Tübingen, GermanyT: +49 (0) 7071 9883 email@example.com
Jason Rando, EVP & COOTiberend Strategic Advisors, New York+1 212 375 firstname.lastname@example.org
View original content:http://www.prnewswire.com/news-releases/the-5th-international-mrna-health-conference-to-showcase-tremendous-advances-in-the-development-of-mrna-drugs-300496052.html
SOURCE International mRNA Health Conference
Subscribe to our Free Newsletters!
Glaucoma is a group of disorders involving the optic nerve, often associated with a rise in ...View All